Radiation Oncologists near Hackensack, NJ

Biography: Dr. Sujit Sheth is the Chiefof the Division of Pediatric Hematology/Oncology and Professor of Clinical Pediatrics at Weill Cornell Medicine andan Attending Pediatrician at NewYork-Presbyterian Phyllis and David Komansky Children's Hospital and Weill Cornell Medical Center. He is also Vice Chair of ClinicalResearch in the Department of Pediatrics at Weill Cornell Medicine.Dr. Shethis board-certified in pediatrics and pediatric hematology/oncology, and is an expert in iron metabolism, thalassemia, and sickle cell disease. Dr. Sheth completed his medical training at the University of Bombay, receiving his medical degree (MBBS) in 1988 and completing his resident specialty training in Pediatrics (MD) in 1991. A year later, he entered Columbia University, College of Physicians & Surgeons as a Post-Doctoral Fellow in Pediatric Hematology/Oncology, completing his fellowship in 1995 and his obligatory additional year of residency in Pediatrics in 1996. Following his residency, Dr. Sheth joined the Columbia University faculty where he was appointed Assistant Professor of Pediatrics. In 2004, he assumed responsibility as Clinical Director of the Pediatric Hematology program, and was promoted to Associate Clinical Professor of Pediatrics. In addition to his clinical work, Dr. Sheth is recognized for his dedication to medical education. At NewYork-Presbyterian Morgan Stanley Children's Hospital, he was voted Attending of the Year by the Pediatric Housestaff in 2010 and nominated for Teacher of the Year eight times, receiving the honor in 1999. He has served on resident selection and education committees, as well as on the Scientific Advisory Board, Irving Center for Clinical Research at NewYork-Presbyterian Hospital.Assuming responsibility as Chief of the Division of Pediatric Hematology and Oncology, Dr. Sheth moved to Weill Cornell in 2011, and was appointed Professor of Clinical Pediatrics in 2012. Since then he has overseen a reorganization and renovation of the Division, practice and clinical facility, adding additional faculty both on the clinical and research arms. Dr. Sheth has also established himself as a physician-scientist with a focus on clinical research related to disorders of iron overload. He has completed work as Principal Investigator on one NIH grant, "Mentored Patient-Oriented Hematology Research Training," and as co-investigator on several other NIH funded studies. He is currently working on research projects and clinical trials related to disorders of red blood cells and iron metabolism. He was appointed Vice-Chair for Clinical Research in 2014, and has worked on improving infrastructure, internal funding and overall support for clinical research in the Department.Related Links:New York Comprehensive Thalassemia Center

Biography: Lisa Bayer, NP is a Radiation Oncology Specialist who practices in New York, NY. Lisa Bayer, NP is affiliated with Newyork-Presbyterian.

Biography: Dr. John Levine, MD is an Oncology Specialist who practices in New York, NY. He is 62 years old and has been practicing for 36 years. Dr. John Levine, MD is affiliated with Mount Sinai Hospital.

Biography: James H. Garvin, MD, PhD, is a board-certified pediatric hematologist-oncologist who specializes in the care of children and adolescents with brain tumors. He is Principal Investigator at CUMC for the Head Start Program of radiation-sparing intensive chemotherapy for infants and young children with brain tumors. He was principal investigator for a Children's Oncolgy Group protocol for childhood ependymoma. He also offers novel therapies for recurrent brain tumors through our program's membership in Developmental Therapeutics Program of the COG. In addition, Dr. Garvin started the pediatric bone marrow transplant program, and continues as a member of the BMT group. He has particular interest in autologous transplant for brain tumors and allogeneic transplant for metabolic disorders and bone marrow failure syndromes, as well as supportive care for BMT patients. Dr. Garvin became interested in pediatric hematology/oncology through research during medical school in the laboratory of a pediatric hematologist. He is a member of numerous professional societies in the field.

Care Philosophy: Augusta University Health is a world class health care network offering the most comprehensive care in the region where your health is our priority As leaders in patient and family centered care our physicians partner with our patients their famil

Biography: Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children's Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation. Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium.

Biography: Manuela Orjuela-Grimm is a molecular epidemiologist and pediatric oncologist whose research focuses on vulnerability (including social) to environmental exposures, gene-nutrient/ environment interactions during windows of susceptibility such as pregnancy, early childhood, adolescence and the development of later genetic and epigenetic changes contributing to poorer health outcomes in childhood and adolescence. She leads EpiRbMx, a long-standing case control/ case series study examining exposure to methyl donors, folate pathway metabolism and risk for retinoblastoma in collaboration with a multidisciplinary team of investigators including the Hospital Infantil de Mexico, the Hospital de Pediatria at the Instituto Mexicano de Seguro Social (IMSS), the Instituto Nacional de Salud Publica (INSP), and the University of Toronto. In collaboration with INSP researchers, Dr. Orjuela is involved in multiple studies examining the intersection between food security, folate-related dietary intake, dietary diversity and environmental exposures in central Mexico, and in immigrants in New York. Interests: social contributors to dietary exposures, gene-nutrient interactions; one carbon donor metabolism; methylation; nutrient and environmental exposures during early life and later genetic and epigenetic effects; dietary assessment in Mexico, in populations on the move in Latin America; effects of acculturation and early life migration on nutrient/ environmental exposures in US Latinos.

Biography: Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients. The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives. NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease. Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease. Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.

Biography: Dr. Dominder Kaur received her medical degree from Maharashtra University of Health Sciences, Nashik in India and completed her pediatric residency at Northwell Health Staten Island University Hospital in New York. She trained in pediatric hematology-oncology at the Mayo Clinic in Minnesota while also receiving a Masters in Clinical and Translational Science from the Mayo School of Graduate Medical Education. She received further specialized training as the Joan Wallick Pediatric Hemostasis Thrombosis fellow at the Nationwide Children's Hospital. She joined as faculty at Columbia University/Columbia Presbyterian Medical Center in December 2018 as an Assistant Professor in Pediatrics. Dr. Kaur was the recipient of the Thrombosis & Hemostasis Societies of North America (THSNA) 2018 Young Investigator Award. Her research focus so far has been on bleeding and thrombotic complications stem cell transplant recipients. She is currently working towards improving screening methodology and approaches to bleeding disorder evaluation in children. She is passionate about improving hematological services for young adults, especially young women with possible bleeding disorders. In collaboration with Adolescent Medicine team, Dr. Kaur staffs the Girls & Young-women's Bleeding Issues Clinic (GYBiC). This clinic is one of only two such centers in New York metropolitan area and offers hematological and adolescent medicine specialty consultations and evaluations in one comprehensive visit. The Girls & Young-women's Bleeding Issues Clinic specializes in the diagnosis and treatment of bleeding (like heavy periods/menorrhagia) and clotting disorders (thrombophilia) and accompanying health issues in young women of reproductive age.

Biography: Dr. Stergios Zacharoulis, MD is a Radiation Oncology Specialist who practices in New York, NY. He is 55 years old and has been practicing for 30 years. Dr. Stergios Zacharoulis, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center and Newyork-Presbyterian/Morgan Stanley Children's Hospital.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Maria is a Pediatric Hemophilia Nurse Practitioner at Weill Cornell Medicine, bringing over nine years of nursing experience to her role. She began her journey at Quinnipiac University, where she graduated with honors in nursing, and then joined Memorial Sloan Kettering Cancer Center, caring for oncology patients. While working full-time as an RN, Maria pursued her master's degree at Pace University, earning her Family Nurse Practitioner (FNP) certification. Her extensive experience and dedication make her an asset in the field of pediatric hemophilia care.

Biography: Ms. Kleinert received her Doctor of Nursing Practice (DNP) degree at Case Western Reserve University and her Pediatric Nurse Practitioner (PNP) degree at New York University, where she also received her MA degree in Adult Primary Care. She has also completed her Master of Public Health degree (MPH) at Columbia University.

Biography: Hanna Rosen, NP is a Radiation Oncology Specialist who practices in New York, NY. Hanna Rosen, NP is affiliated with Weill Cornell Medical Center.

Care Philosophy: Alexander J. Chou, MD, is a pediatric oncologist specializing in the treatment of pediatric sarcomas, rare cancers of the bone and soft tissues at Children's Hospital at Montefiore. Dr. Chou, along with his colleagues, provides state-of-the-art therapies to patients with sarcomas in a comprehensive and multidisciplinary setting. Dr. Chou is the Clinical Director of the Pediatric Sarcoma Service at the Children's Hospital at Montefiore and an Associate Professor of Pediatrics at the Albert Einstein College of Medicine.Dr. Chou earned his Bachelor of Arts in Biology in 1994 at the University of Pennsylvania. In 1998, he received his Doctor of Medicine at Cornell University Medical College in New York City. Following this, he completed an internship and residency in Pediatrics at New York-Presbyterian Hospital/Weill Cornell Medical Center in New York City.